Last reviewed · How we verify

NCT06705985: EARTH

Early Artificial Lateral Prosthesis

Not yet recruiting NA Last updated 26 November 2024
What this trial tests

NA trial testing Implantation of lateral meniscus prosthesis in Post-Meniscectomy Pain Syndrome in 16 participants. Not yet recruiting.

Timeline
21 November 2024
Primary endpoint
1 February 2026
1 January 2028

Quick facts

Lead sponsorATRO Medical B.V.
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposeother
Enrollment16
Start date21 November 2024
Primary completion1 February 2026
Estimated completion1 January 2028
Sites1 location across Netherlands

Drugs / interventions tested

Conditions studied

Sponsor

ATRO Medical B.V.

Who can join

Adults 18 to 70, any sex, with Post-Meniscectomy Pain Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The device subject to this clinical investigation has been developed for treating patients with a history of partial or total meniscectomy, who suffer from symptomatic unicompartmental pain in the meniscus-deficient knee: the post-meniscectomy pain syndrome. The intended purpose of the system is to replace the lateral native meniscus and its function after meniscectomy by distributing tibio-femoral loads and provide a clinically relevant reduction of pain and improvement of joint function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other ATRO Medical B.V. trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06705985.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing